Helix Nanotechnologies
Pre-clinicalDevelops nanoparticle-based drug delivery platforms for targeted cancer therapies.
Founded
2016
Focus
RNA & Gene Therapy
About
Develops nanoparticle-based drug delivery platforms for targeted cancer therapies.
Funding History
2Total raised: $6.8M
Grant$2.3MNational Institutes of HealthJan 15, 2023
Seed$4.5MUndisclosedMay 15, 2022
Company Info
TypePrivate
Founded2016
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile